by Jordana Choucair | Dec 28, 2021 | Payers
Goldman Sachs announced it will require employees and visitors to its U.S. offices to have booster shots, beginning in February. Beginning in January, in-person staff will get tested twice weekly. Goldman was among the Wall Street banks that have pushed hardest to...
by Jordana Choucair | Dec 28, 2021 | D.C. News
During a call with the National Governors Association Monday, President Biden acknowledged the states will need to take the lead in controlling the COVID-19 pandemic. The president pledged federal support, but stated, “There is no federal solution. This gets solved at...
by Jordana Choucair | Dec 23, 2021 | Life Sciences
Novavax and AstraZeneca announced that its COVID-19 vaccine is effective in generating an immune response against the Omicron variant. Yesterday, Novavax said early data from its booster and adolescent studies showed “broad cross-reactivity” against Omicron and other...
by Jordana Choucair | Dec 23, 2021 | Life Sciences
The FDA authorized Pfizer Inc.’s Paxlovid for high-risk patients 12 and older, making it the first antiviral pill to treat COVID-19 in the United States. Even so, it will likely be months before the pills are widely available. Jeff Zients, coordinator of the...
by Jordana Choucair | Dec 23, 2021 | D.C. News
The Supreme Court said it will fast-track a review of the Biden administration’s COVID-19 vaccination rules for private employers and health care workers, with oral arguments set for January 7. The mandates are still working their way through the lower courts,...
Recent Comments